Supplier Type
- Trader
- contract manufacturer
- Reagent
- Manufacturer
- custom synthesis
Supplier Region
- Tamil Nadu(1)
- Mumbai(18)
- Maharashtra(11)
- Andhra Pradesh(2)
- Delhi(2)
- Ahmedabad(3)
- Pune(3)
- Hyderabad(15)
- Gujarat(9)
- Karnataka(4)
- Bangalore(2)
- Uttar Pradesh(1)
- Vadodara(1)
- Nagpur(1)
- Punjab(1)
Purity
- Salicylic Acid
- Rasagiline Mesylate Impurity C
- NLT95%
- NLT 95%
- NLT 90%
- more than 95%
- more than 90%
- Mesalazine EP Impurity H
- Mathadone (M225865) impurity. Used in synthesis of methadone, antispasmodics and other pharmaceutica
- Greater than 99%
- Empagliflozin intermediate, Dapagliflozin Impurity
- Dipropargyl r- amino indane
- Dapagliflozin Intermediate, Dapagliflozin Impurity
- API Impurity / In-house working standard
- Acetylsalicylic Acid EP Impurity C
- 99.99%
- 99.98%
- 99.95%
- 99.91%
- 99.86%
- 99.85%
- 99.73%
- 99.42%
- 99.29%
- 99%+
- 99% min
- 99%
- 99 %
- 98+
- 98.60%
- 98.12%
- 98%
- 98 %
- 97-99%
- 97-99 %
- 97.57%
- 97%
- >97%
- 97 %
- 96.80%
- 96.39%
- 96.14%
- 96%
- 95.48%
- 95%
- >95%
- >92%
- 90%
- >90%
- 25 MG 50 MG 100 MG 250 MG EXTRA
- (R)-N,N-di(prop-2-yn-1-yl)-2,3- dihydro-1
Package
- 25MG
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 10g
- 50g
- 100g
- 500g
- 50kg
- 500kg
- 95NLT %
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 1g
- 5g
- 25g
- 1kg
- 5kg
- 10kg
- 25kg
- 100kg
- 156kg
- 1MT
-
Atorvastatin
134523-00-5
-
1,5-Dihydroxy naphthalene
83-56-7
-
Atorvastatin calcium
134523-03-8
-
DL-Tartaric acid
133-37-9
-
2',5'-Dihydroxyacetophenone
490-78-8
-
ERYTHROMYCIN IMPURITY N
-
L 683519
132172-14-6
-
3'-Demethyl-12-deoxyerythromycin
33442-56-7
-
AzithroMycin IMpurity C -
4,6-Diacetylresorcinol
2161-85-5
Benzaldehyde, 2-bromo-3,4-dihydroxy-5-methoxy- 65144-12-9
1,3,4,6,7,11b-Hexahydro-9,10-dihydroxy-3-(2-methylpropyl)-2H-Benzo[a]quinolizin-2-one 89929-27-1
Atorvastatin 134523-00-5
Atorvastatin calcium 134523-03-8
1 6 Dihydroxy 2.5 Dioxyhexane, Liquid, 200 Kgs 3586-55-8